HLA-G molecules in pregnancy and their possible role in assisted reproductive technology

References

• Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol.29(3), 125–132 (2008).
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Solier C. Is antigen presentation the primary function of HLA-G? Microbes Infect.3(4), 323–332 (2001).
   Google Scholar
• Bainbridge D, Ellis S, Le Bouteiller P, Sargent I. HLA-G remains a mystery. Trends Immunol.22(10), 548–552 (2001).
   PubMedGoogle Scholar
• Hviid TV, Rizzo R, Melchiorri L, Stignani M, Baricordi OR. Polymorphism in the 5´ upstream regulatory and 3´ untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum. Immunol.67, 53–62 (2006).
   PubMed Web of Science ®Google Scholar
• Hviid TV, Hylenius S, Rørbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics55, 63–79 (2003).
   PubMed Web of Science ®Google Scholar
• Rizzo R, Hviid TV, Stignani M et al. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics57(3–4), 172–181 (2005).
   PubMed Web of Science ®Google Scholar
• Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics56, 135–141 (2004).
   PubMedGoogle Scholar
• Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens72, 335–341 (2008).
   PubMed Web of Science ®Google Scholar
• Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3´ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum. Immunol.64(11), 1005–1010 (2003).
   PubMed Web of Science ®Google Scholar
• Dong Y, Lieskovska J, Kedrin D, Porcelli S, Mandelboim O, Bushkin Y. Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum. Immunol.64, 802–810 (2003).
   PubMed Web of Science ®Google Scholar
• Lin A, Yan WH, Xu HH et al. HLA-G expression in human ovarian carcinoma counteracts NK cell function. Ann. Oncol.18(11), 1804–1809 (2007).
   PubMed Web of Science ®Google Scholar
• Contini P, Ghio M, Poggi A et al. Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8 cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol.33, 125–134 (2003).
   PubMed Web of Science ®Google Scholar
• Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4 T cells suppresses the allo-proliferative response: a CD4 T cell regulatory mechanism. Proc. Natl Acad. Sci. USA98, 12150–12155 (2001).
   PubMed Web of Science ®Google Scholar
• Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur. J. Immunol.35, 1133–1142 (2005).
   PubMed Web of Science ®Google Scholar
• Le Rond S, Azéma C, Krawice-Radanne I et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J. Immunol.176, 3266–3276 (2006).
   PubMed Web of Science ®Google Scholar
• Fons P, Chabot S, Cartwright JE et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood108, 2608–2615 (2006).
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Bryceson YT, Kuppusamy SP et al. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol.4, e9 (2006).
   PubMed Web of Science ®Google Scholar
• Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens64, 215–225 (2004).
   Google Scholar
• Baricordi OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases Inflamm. Allergy Drug Targets7(2), 67–74 (2008).
   PubMedGoogle Scholar
• Hunt JS. Stranger in a strange land. Immunol. Rev.213, 36–47 (2006).
   PubMed Web of Science ®Google Scholar
• Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol.44, 320–338 (1953).
   Google Scholar
• Piccinni MP. T cells in normal pregnancy and recurrent pregnancy loss. Reprod. Biomed Online13(6), 840–844 (2006).
   PubMed Web of Science ®Google Scholar
• Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in maternal blood during pregnancy. Am. J. Obstet. Gynecol.183(3), 682–688 (2000).
   PubMed Web of Science ®Google Scholar
• Hackmon R, Hallak M, Krup M et al. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy. Fetal Diagn. Ther.19(5), 404–409 (2004).
   PubMed Web of Science ®Google Scholar
• Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am. J. Obstet. Gynecol.193, 204–208 (2005).
   PubMed Web of Science ®Google Scholar
• Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, Sohn C. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am. J. Reprod Immunol.57(4), 277–286 (2007).
   PubMed Web of Science ®Google Scholar
• Rizzo R, Stignani M, Amoudruz P et al. Allergic women have reduced sHLA-G plasma levels at delivery. Am. J. Reprod. Immunol.61(5), 368–376 (2009).
   Google Scholar
• Hackmon R, Koifman A, Hyodo H, Glickman H, Sheiner E, Geraghty DE. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia. Am. J. Obstet. Gynecol.197(3), 255.e1–255.e5 (2007).
   PubMedGoogle Scholar
• Pfeiffer KA, Rebmann V, Pässler M et al. Soluble histocompatibility antigen levels in early pregnancy after IVF. Hum. Immunol.61, 559–564 (2000).
   PubMedGoogle Scholar
• Hanna J, Goldman-Wohl D, Hamani Y et al. Decidual NK cells regulate key developmental processes at the human fetal–maternal interface. Nat. Med.12, 1065–1074 (2006).
   PubMed Web of Science ®Google Scholar
• van der Meer A, Lukassen HGM, van Lierop MJC et al. Membrane-bound HLA-G activates proliferation and interferon-γ production by uterine natural killer cells Mol. Hum. Reprod.10, 189–195 (2004).
   Google Scholar
• Ellis SA, Sargent IL, Redman CW, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology59, 595–601 (1986).
   Web of Science ®Google Scholar
• Hunt JS, Morales PJ, Pace JL, Fazleabas AT, Langat DK. A commentary on gestational programming and functions of HLA-G in pregnancy. Placenta28, S57–S63 (2007).
   PubMedGoogle Scholar
• Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol.37(7), 1924–1937 (2007).
   Web of Science ®Google Scholar
• Ishitani A, Sageshima N, Lee N et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal–placental immune recognition. J. Immunol.171, 1376–1384 (2003).
   PubMedGoogle Scholar
• Morales PJ, Pace JL, Platt JS et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J. Immunol.171, 6215–6224 (2003).
   PubMed Web of Science ®Google Scholar
• LeMaoult J, Rouas-Freiss N, Carosella ED. HLA-G5 expression by trophoblast cells: the facts. Mol. Hum. Reprod.11(10), 719–722 (2005).
   Google Scholar
• Blaschitz A, Juch H, Volz A et al. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms. Mol. Hum. Reprod.11, 699–710 (2005).
   Google Scholar
• Goldman-Wohl D, Ariel I, Greenfield C et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol. Hum. Reprod.6, 88–95 (2000).
   PubMed Web of Science ®Google Scholar
• Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am. J. Obstet. Gynecol.191, 525–529 (2004).
   PubMed Web of Science ®Google Scholar
• Jurisicova A, Casper RF, MacLusky NJ, Librach CL. Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertil. Steril.65, 997–1002 (1996).
   Google Scholar
• Jurisicova A, Casper RF, MacLusky NJ, Mills GB, Librach CL. HLA-G expression during preimplantation human embryo development. Proc. Natl Acad. Sci. USA93, 161–165 (1996).
   PubMed Web of Science ®Google Scholar
• Yao YQ, Barlow DH, Sargent IL. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J. Immunol.175(12), 8379–8385 (2005).
   PubMedGoogle Scholar
• Hunt JS, McIntire RH, Petroff MG. Immunobiology of human pregnancy. In: Knobil and Neill’s Physiology of Reproduction (Volume 2). Neill JD (Ed.). Elsevier/Academic Press St Louis, MO, USA, 2759–2785 (2006).
   Google Scholar
• Desoye G, Dohr GA, Motter W et al. Lack of HLA class I and class II antigens on human preimplantation embryos. J. Immunol.140, 4157–4159 (1988).
   Google Scholar
• Roberts JM, Taylor CT, Melling GC, Kingsland CR, Johnson PM. Expression of the CD46 antigen, and absence of class I MHC antigen, on the human oocyte and preimplantation blastocyst. Immunology75, 202–205 (1992).
   Google Scholar
• Hiby SE, King A, Sharkey A, Loke YW. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens53, 1–13 (1999).
   Google Scholar
• Shaikly VR, Morrison IE, Taranissi M et al. Analysis of HLA-G in maternal plasma, follicular fluid, and preimplantation embryos reveal an asymmetric pattern of expression. J. Immunol.180(6), 4330–4337 (2008).
   Google Scholar
• Wang Q, Zhuang GL, Zhou CQ, Li TC et al. Expression of certain HLA-I types in cleavage-stage embryos. Reprod. Biomed Online18(2), 244–250 (2009).
   Google Scholar
• Menicucci A, Noci I, Fuzzi B et al. Non-classic sHLA class I in human oocyte culture medium. Hum. Immunol.60(11), 1054–1057 (1999).
   Google Scholar
• Fuzzi B, Rizzo R, Criscuoli L et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur. J. Immunol.32, 311–315 (2002).
   PubMedGoogle Scholar
• Rizzo R, Baricordi OR. HLA-G expression and regulation in early embryos. Am. J. Reprod. Immunol.56(1), 17 (2006).
   Google Scholar
• Rizzo R, Melchiorri L, Stignani M, Baricordi OR. HLA-G expression is a fundamental prerequisite to pregnancy. Hum. Immunol.68(4), 244–250 (2007).
   PubMed Web of Science ®Google Scholar
• Roussev RG, Keskintepe L, Coulam CB. Soluble HLA-G (sHLA-G) in human embryo culture media: a useful marker for assessing embryo quality and implantation potential for IVF. Fertil. Steril.80, S12–S13 (2003).
   Google Scholar
• Sher G, Keskintepe L, Nouriani M et al. Expression of sHLA-G in supernatants of individually cultured 46-h embryos: a potentially valuable indicator of ‘embryo competency’ and IVF outcome. Reprod. Biomed Online9(1), 74–78 (2004).
   PubMed Web of Science ®Google Scholar
• Criscuoli L, Rizzo R, Fuzzi B et al. Lacking of HLA-G expression in early embryos is not related to germinal defects or impairment in IL-10 embryos production. Gynecol. Endocrinol.20(5), 264–269 (2005).
   PubMed Web of Science ®Google Scholar
• Noci I, Fuzzi B, Rizzo R et al. Embryonic soluble HLA-G as a marker of developmental potential in embryos. Hum. Reprod.20(1), 138–146 (2005).
   PubMed Web of Science ®Google Scholar
• Sher G, Keskintepe L, Batzofin J et al. Influence of early ICSI-derived embryo sHLA-G expression on pregnancy and implantation rates: a prospective study. Hum. Reprod.20(5), 1359–1363 (2005).
   PubMedGoogle Scholar
• Sher G, Keskintepe L, Fisch JD et al. Soluble human leukocyte antigen G expression in Phase I culture media at 46 hours after fertilization predicts pregnancy and implantation from day 3 embryo transfer. Fertil. Steril.83(5), 1410–1413 (2005).
   PubMedGoogle Scholar
• Yie SM, Balakier H, Motamedi G et al. Secretion of human leukocyte antigen-G by human embryos is associated with a higher in vitro fertilization pregnancy rate. Fertil. Steril.83(1), 30–36 (2005).
   Google Scholar
• Wang Q, Zhuang GL, Zhou CQ et al. Expression of soluble human leukocyte antigen G and its relationship to embryo development. Zhonghua Fu Chan Ke Za Zhi40(2), 112–115 (2005).
   Google Scholar
• Desai N, Filipovits J, Goldfarb J. Secretion of soluble HLA-G by day 3 human embryos associated with higher pregnancy and implantation rates: assay of culture media using a new ELISA kit. Reprod. Biomed Online.13(2), 272–277 (2006).
   Google Scholar
• Rebmann V, Switala M, Eue I et al. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum. Immunol.68(4), 251–258 (2007).
   PubMedGoogle Scholar
• Fisch JD, Keskintepe L, Ginsburg M et al. Graduated Embryo Score and soluble human leukocyte antigen-G expression improve assisted reproductive technology outcomes and suggest a basis for elective single-embryo transfer. Fertil. Steril.87(4), 757–763 (2007).
   PubMedGoogle Scholar
• Rizzo R, Fuzzi B, Stignani M et al. Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? J. Reprod. Immunol.74(1–2), 133–142 (2007).
   PubMed Web of Science ®Google Scholar
• Lédée N, Thonon F, Perrier d’hauterive S et al. Significance of soluble HLA-G detection in follicular fluids and embryo supernatants in IVF/ICSI cycles. Am. J. Reprod. Immunol.57, S227 (2007).
   Google Scholar
• Vercammen MJ, Verloes A, Van de Velde H, Haentjens P. Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis. Hum. Reprod. Update14(3), 209–218 (2008).
   Google Scholar
• Pfeiffer KA, Fimmers R, Engels G, van der Ven H, van der Ven K. The HLA-G genotype is potentially associated with idiopathic recurrent spontaneous abortion. Mol. Hum. Reprod.7(4), 373–378 (2001).
   PubMed Web of Science ®Google Scholar
• Ménézo Y, Elder K, Viville S. Soluble HLA-G release by the human embryo: an interesting artefact? Reprod. Biomed Online13, 763–764 (2006).
   Google Scholar
• Sargent I, Swales A, Ledee N, Kozma N, Tabiasco J, Le Bouteiller P. sHLA-G production by human IVF embryos: can it be measured reliably? J. Reprod. Immunol.75(2), 128–132 (2007).
   Google Scholar
• Devreker F, Englert Y. In vitro development and metabolism of the human embryo up to the blastocyst stage. Eur. J. Obstet. Gynecol. Reprod. Biol.92(1), 51–56 (2000).
   Google Scholar
• Chen L, Nakai M, Belton RJ Jr, Nowak RA. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development. Reproduction133(2), 405–414 (2007).
   PubMed Web of Science ®Google Scholar
• Díaz-Lagares A, Alegre E, Lemaoult J, Carosella ED, González A. Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu. Immunology126(3), 436–445 (2009).
   PubMed Web of Science ®Google Scholar
• Nieder GL. Analysis of proteins secreted by mouse embryos developing in vivo and in vitro. J. Exp. Zool.252(2), 134–142 (1989).
   Google Scholar
• van Lierop MJ, Wijnands F, Loke YW et al. Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B. Mol. Human Reprod.8(8), 776–784 (2002).
   Google Scholar
• Sageshima N, Shobu T, Awai K et al. Soluble HLA-G is absent from human embryo cultures: a reassessment of sHLA-G detection methods. J. Reprod. Immunol.75(1), 11–22 (2007).
   Google Scholar
• Warner CM, Lampton PW, Newmark JA, Cohen J. Symposium: innovative techniques in human embryo viability assessment. Soluble human leukocyte antigen-G and pregnancy success. Reprod. Biomed Online17(4), 470–485 (2008).
   Google Scholar
• Ménézo Y, Chouteau J, Guyader-Joly C, Veiga A. Sequential media: why and how? Contracept. Fertil. Sex.27(6), 449–451 (1999).
   Google Scholar
• Lonergan P, Rizos D, Gutierrez-Adan A, Fair T, Boland M. Oocyte and embryo quality: effect of origin, culture conditions and gene expression patterns. Reprod. Dom. Anim.38, 259–267 (2003).
   PubMed Web of Science ®Google Scholar
• Mann M, Lee S, Doherty A, Verona R, Nolen L, Schultz R, Bartolomei M. Selective loss of imprinting in the placenta following preimplantation development in culture. Development131, 3727–3735 (2004).
   PubMed Web of Science ®Google Scholar
• Niemann H, Wrenzycki C. Alterations of expression of developmentally important genes in preimplantation bovine embryos by in vitro culture conditions: implications for subsequent development. Theriogenology53, 21–34 (2000).
   PubMedGoogle Scholar
• Rinaudo P, Schultz R. Effects of embryo culture on global pattern of gene expression in preimplantation mouse embryos. Reproduction128, 301–311 (2004).
   Google Scholar
• Behr B, Wang H. Effects of culture conditions on IVF outcome. Eur. J. Obstet. Gynecol. Reprod. Biol.115(Suppl.), S72–S76 (2004).
   Google Scholar
• Ecker D, Stein P, Xu Z et al. Long-term effects of culture of preimplantation mouse embryos on behavior. Proc. Natl Acad. Sci. USA101, 1595–1600 (2004).
   PubMed Web of Science ®Google Scholar
• Artini PG, Valentino V, Cela V, Cristello F, Vitè A, Genazzani AR. A randomized control comparison study of culture media (HTF versus P1) for human in vitro fertilization. Eur. J. Obstet. Gynecol. Reprod. Biol.116(2), 196–200 (2004).
   Google Scholar
• Poláková K, Kuba D, Russ G. The 4H84 monoclonal antibody detecting β2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Hum. Immunol.65(2), 157–162 (2004).
   Google Scholar
• Blaschitz A, Hutter H, Leitner V et al. Reaction patterns of monoclonal antibodies to HLA-G in human tissues and on cell lines: a comparative study. Hum. Immunol.61(11), 1074–1085 (2000).
   Google Scholar
• Tabiasco J, d’Hauterive SP, Thonon F et al. Soluble HLA-G in IVF/ICSI embryo culture supernatants does not always predict implantation success: a multicentre study. Reprod. Biomed Online18(3), 374–381 (2009).
   Google Scholar
• Nothias JY, Majumder S, Kaneko KJ, DePamphilis ML. Regulation of gene expression at the beginning of mammalian development. J. Biol. Chem.270, 22077–22080 (1995).
   PubMedGoogle Scholar
• Mermillod P, Dalbiès-Tran R, Uzbekova S et al. Factors affecting oocyte quality: who is driving the follicle? Reprod. Domest. Anim.43(Suppl. 2), 393–400 (2008).
   Google Scholar
• Mendoza C, Ruiz-Requena E, Ortega E et al. Follicular fluid markers of oocyte developmental potential. Hum. Reprod.17(4), 1017–1022 (2002).
   PubMed Web of Science ®Google Scholar
• Baka S, Malamitsi-Puchner A. Novel follicular fluid factors influencing oocyte developmental potential in IVF: a review. Reprod. Biomed Online12(4), 500–506 (2006).
   PubMed Web of Science ®Google Scholar
• Rizzo R, Dal Canto MB, Stignani M et al. Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex. J. Mol. Med. DOI: 10.3892/ijmm (2009) (Epub ahead of print).
   Google Scholar
• Gilchrist RB, Ritter LJ, Armstrong DT. Oocyte–somatic cell interactions during follicle development in mammals. Anim. Reprod. Sci.82–83, 431–446 (2004).
   Google Scholar
• Feuerstein P, Cadoret V, Dalbies-Tran R, Guerif F, Bidault R, Royere D. Gene expression in human cumulus cells: one approach to oocyte competence. Hum. Reprod.22, 3069–3077 (2007).
   PubMed Web of Science ®Google Scholar
• Cillo F, Brevini TA, Antonini S, Paffoni A, Ragni G, Gandolfi F. Association between human oocyte developmental competence and expression levels of some cumulus genes. Reproduction134, 645–650 (2007).
   PubMed Web of Science ®Google Scholar
• Steptoe PC. Clinical aspects of pregnancies established with cleaving embryos grown in vitro. Br. J. Obstet. Gynecol.87, 757–768 (1980)
   PubMedGoogle Scholar
• Schultz RM. The science of ART. Science296, 2188–2190 (2002).
   PubMed Web of Science ®Google Scholar
• Sutcliffe AG. IVF Children: The First Generation. Parthenon Publishing, NY, USA (2002).
   Google Scholar
• Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol.29, 313–321 (2008).
   PubMed Web of Science ®Google Scholar
• Paul P, Rouas-Freiss N, Moreau P et al. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum. Immunol.61(11), 1177–1195 (2000).
   PubMedGoogle Scholar
• Menier C, Saez B, Horejsi V et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum. Immunol.64(3), 315–326 (2003).
   PubMed Web of Science ®Google Scholar
• Niemeyer CM, Adler M, Wacker R. Detecting antigens by quantitative immuno-PCR. Nat. Protoc.2(8), 1918–1930 (2007).
   PubMed Web of Science ®Google Scholar
• Borgatti M, Rizzo R, Canto MB et al. Release of sICAM-1 in oocytes and in vitro fertilized human embryos. PLoS ONE3(12), e3970 (2008).
   Google Scholar